| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
|
Ho, A.L.
|
|
|
27 |
10 |
p. 1902-1908
|
artikel
|
| 2 |
A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients
|
Biehl, L.M.
|
|
|
27 |
10 |
p. 1916-1922
|
artikel
|
| 3 |
Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society's Make Sense Campaign
|
Reich, M.
|
|
|
27 |
10 |
p. 1848-1854
|
artikel
|
| 4 |
Chemoprevention of hepatocellular carcinoma in people affected by hepatitis C virus: what changes does the introduction of direct-acting antiviral agents make?
|
Testino, G.
|
|
|
27 |
10 |
p. 1970
|
artikel
|
| 5 |
Chemotherapy remains an essential element of personalized care for persons with lung cancers
|
Hellmann, M.D.
|
|
|
27 |
10 |
p. 1829-1835
|
artikel
|
| 6 |
Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
|
Imaoka, H.
|
|
|
27 |
10 |
p. 1879-1886
|
artikel
|
| 7 |
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA
|
Gremel, G.
|
|
|
27 |
10 |
p. 1959-1965
|
artikel
|
| 8 |
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
|
Mavroudis, D.
|
|
|
27 |
10 |
p. 1873-1878
|
artikel
|
| 9 |
Editorial board
|
|
|
|
27 |
10 |
p. ii-iii
|
artikel
|
| 10 |
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study
|
Long, G.V.
|
|
|
27 |
10 |
p. 1940-1946
|
artikel
|
| 11 |
Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy
|
Novotny Jr, J.F.
|
|
|
27 |
10 |
p. 1966-1969
|
artikel
|
| 12 |
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
|
Patnaik, A.
|
|
|
27 |
10 |
p. 1928-1940
|
artikel
|
| 13 |
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis †
|
De Ruysscher, D.
|
|
|
27 |
10 |
p. 1818-1828
|
artikel
|
| 14 |
Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database
|
Brower, J.V.
|
|
|
27 |
10 |
p. 1887-1894
|
artikel
|
| 15 |
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
|
Dieci, M.V.
|
|
|
27 |
10 |
p. 1867-1873
|
artikel
|
| 16 |
Ipilimumab-related hypophysitis may precede severe CNS immune attack
|
Köessler, T.
|
|
|
27 |
10 |
p. 1975-1976
|
artikel
|
| 17 |
Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study
|
Nestoriuc, Y.
|
|
|
27 |
10 |
p. 1909-1915
|
artikel
|
| 18 |
Is radical chemo-radiotherapy appropriate in patients with stage IV non-small-cell lung cancer due to cervical lymph node metastases?
|
de Boer, P.
|
|
|
27 |
10 |
p. 1973
|
artikel
|
| 19 |
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC) †
|
Joerger, M.
|
|
|
27 |
10 |
p. 1895-1902
|
artikel
|
| 20 |
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma †
|
Dickson, M.A.
|
|
|
27 |
10 |
p. 1855-1860
|
artikel
|
| 21 |
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial
|
Früh, M.
|
|
|
27 |
10 |
p. 1971-1973
|
artikel
|
| 22 |
Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis
|
Mei, Z.B.
|
|
|
27 |
10 |
p. 1836-1848
|
artikel
|
| 23 |
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
|
Saiag, P.
|
|
|
27 |
10 |
p. 1947
|
artikel
|
| 24 |
Pulmonary sarcoidosis or post-immunotherapy granulomatous reaction induced by the anti-PD-1 monoclonal antibody pembrolizumab: the terminology is not the key point
|
Cousin, S.
|
|
|
27 |
10 |
p. 1974-1975
|
artikel
|
| 25 |
Reply to ‘Chemoprevention of hepatocellular carcinoma in people affected by hepatitis C virus: what changes does the introduction of direct-acting antiviral agents make?’
|
Wirth, T.C.
|
|
|
27 |
10 |
p. 1971
|
artikel
|
| 26 |
Searching for aurora in the night of sarcoma phase II trials: isn't it time to move to second gear?
|
Toulmonde, M.
|
|
|
27 |
10 |
p. 1815-1817
|
artikel
|
| 27 |
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab
|
Lassau, N.
|
|
|
27 |
10 |
p. 1922-1928
|
artikel
|
| 28 |
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
|
Fumagalli, D.
|
|
|
27 |
10 |
p. 1860-1866
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
27 |
10 |
p. iv-vi
|
artikel
|
| 30 |
Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer
|
Mansfield, A.S.
|
|
|
27 |
10 |
p. 1953-1958
|
artikel
|
| 31 |
The clinical dilemma of grade 3 follicular lymphoma
|
Sorigue, M.
|
|
|
27 |
10 |
p. 1974
|
artikel
|
Tijdschrift beschrijving